Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Horizon Pharma, Inc. (HZNP)

« Back to company index

HZNP Chatter Timeline

Stock Ticker for HZNP

Most Active Tweeters for HZNP

UserTweets
@Tickeron 8
@AmericanBanking 5
@Gambiste1 4
@TickerReport 3
@VisualStockRSRC 3

Recent Tweets for HZNP

Tickeron @Tickeron
$HZNP in Uptrend: Stochastic indicator peaks and leaves oversold zone. View odds for this and other indicators:… https://t.co/Cm8Aptxgt3
11:09am
registrarjourn @registrarjourn
Horizon Therapeutics $HZNP Now Covered by Analysts at Guggenheim https://t.co/cf0YEarWsf
6:09am
EnterpriseLeade @EnterpriseLeade
Horizon Therapeutics $HZNP Now Covered by Analysts at Guggenheim https://t.co/TKoqgsCHRy
6:09am
AmericanBanking @AmericanBanking
Horizon Therapeutics PLC $HZNP Expected to Announce Earnings of $0.48 Per Share https://t.co/XA5gcyxZqO #stocks
2:09am
Tickeron @Tickeron
$HZNP in Uptrend: Stochastic indicator leaves oversold zone. View odds for this and other indicators:… https://t.co/FSOq2sKb9o
12:09am
ZolmaxNews @ZolmaxNews
Horizon Therapeutics $HZNP PT Set at $35.00 by Stifel Nicolaus https://t.co/2yOAGZ7CcD
September 15th 2019, 11:09pm
OlympiaReport @OlympiaReport
Horizon Therapeutics $HZNP PT Set at $35.00 by Stifel Nicolaus https://t.co/rB6RhFLmeE
September 15th 2019, 11:09pm
WeekHerald @WeekHerald
Horizon Therapeutics $HZNP Given a $35.00 Price Target at Stifel Nicolaus https://t.co/R8Jhg4Q7af
September 15th 2019, 11:09pm
AmericanBanking @AmericanBanking
Horizon Therapeutics $HZNP Given a $35.00 Price Target by Stifel Nicolaus Analysts https://t.co/VYQJ1WJXVb #stocks
September 15th 2019, 11:09pm
dispatchtribune @dispatchtribune
Horizon Therapeutics $HZNP Given a $35.00 Price Target at Stifel Nicolaus https://t.co/WG53rJqXEX
September 15th 2019, 11:09pm
TickerReport @TickerReport
Guggenheim Begins Coverage on Horizon Therapeutics $HZNP https://t.co/a6yqO5EwqZ
September 15th 2019, 2:09pm
TheMarketsDaily @TheMarketsDaily
Guggenheim Begins Coverage on Horizon Therapeutics $HZNP https://t.co/WpnkME7KHO
September 15th 2019, 10:09am
stocknewstimes @stocknewstimes
Horizon Therapeutics $HZNP Now Covered by Analysts at Guggenheim https://t.co/BnB0kB58Wf
September 15th 2019, 10:09am
ConsumerFeed @ConsumerFeed
Horizon Therapeutics PLC $HZNP Director James Samuel Shannon Sells 15,500 Shares of Stock https://t.co/2wYknQeS6A
September 14th 2019, 2:09pm
1MinuteStock @1MinuteStock
Btw, Estimated #Earnings Per Share for $HZNP is $0.23 it's 0.87% of the current price https://t.co/Jo6kVkqljk
September 14th 2019, 3:09am
ConsumerFeed @ConsumerFeed
Horizon Therapeutics Director James Samuel Shannon Sells $412,145.00 in $HZNP https://t.co/wIU0U71BnV
September 14th 2019, 3:09am
insiderbuyings @insiderbuyings
$HZNP new insider selling: 25000 shares. https://t.co/sHI6hcLYbj
September 13th 2019, 11:09pm
AmericanBanking @AmericanBanking
Insider Selling: Horizon Therapeutics PLC $HZNP Director Sells 15,500 Shares of Stock https://t.co/NJdzjljPXz #stocks
September 13th 2019, 9:09pm
TranscriptDaily @TranscriptDaily
Insider Selling: Horizon Therapeutics PLC $HZNP EVP Sells 17,838 Shares of Stock https://t.co/kbA8WhiR2z
September 13th 2019, 9:09pm
dakotafinancial @dakotafinancial
Horizon Therapeutics PLC $HZNP Director Sells $412,145.00 in Stock https://t.co/BQbopZgDmv
September 13th 2019, 9:09pm
InsiderAlertsIA @InsiderAlertsIA
$HZNP: New Insider Filing on EVP, Chief Human Resources Off IRINA KONSTANTINOVSKY: https://t.co/1aBpqhEl40
September 13th 2019, 8:09pm
StockTexts @StockTexts
$HZNP Horizon Pharma plc SEC Filing: Form 4 https://t.co/89BNPzC9m6
September 13th 2019, 7:09pm
StockTexts @StockTexts
$HZNP Horizon Pharma plc SEC Filing: Form 4 https://t.co/89BNPzkxXw
September 13th 2019, 7:09pm
StockTexts @StockTexts
$HZNP Horizon Pharma plc SEC Filing: Form 4 https://t.co/yvQo1i8EWh
September 13th 2019, 7:09pm
confcalltran @confcalltran
Horizon Pharma director just cashed-in 25,000 options https://t.co/pyT6UvKx6T $HZNP
September 13th 2019, 6:09pm
VisualStockRSRC @VisualStockRSRC
$HZNP - Statement of Changes in Beneficial Ownership (4) https://t.co/Z2FzBZLm1D
September 13th 2019, 6:09pm
VisualStockRSRC @VisualStockRSRC
$HZNP - Statement of Changes in Beneficial Ownership (4) https://t.co/DQE6OPgZNa
September 13th 2019, 6:09pm
confcalltran @confcalltran
EVP of Horizon Pharma just disposed of 8,919 shares https://t.co/LUrDI5ZIOX $HZNP
September 13th 2019, 6:09pm
chaffeybreeze @chaffeybreeze
Horizon Therapeutics $HZNP Coverage Initiated by Analysts at Guggenheim https://t.co/yuUam1qxae #stocks
September 13th 2019, 6:09pm
IRAMarketReport @IRAMarketReport
Horizon Therapeutics $HZNP Coverage Initiated by Analysts at Guggenheim https://t.co/vVdqaEwnb4 #markets
September 13th 2019, 6:09pm
ChartMill @ChartMill
$HZNP has a Return On Assets of 1.87%. This is amongst the best returns in the industry. https://t.co/EJAWaFGnhH https://t.co/Ilh68sC6fv
September 13th 2019, 5:09pm
Tickeron @Tickeron
$HZNP in Uptrend: 50-day Moving Average moved above 200-day Moving Average on November 24, 2017. View odds for this… https://t.co/MjRfpk60wC
September 13th 2019, 2:09pm
StockflareUS @StockflareUS
$HZNP: Forecast sales for Horizon Therapeutics PLC are no longer forecast to rise this year. (https://t.co/TAkodEXUH6)
September 13th 2019, 5:09am
Tickeron @Tickeron
$HZNP in Uptrend: 50-day Moving Average broke above 200-day Moving Average on November 24, 2017. View odds for this… https://t.co/kqmwbA6fMx
September 12th 2019, 11:09am
AmericanBanking @AmericanBanking
Horizon Therapeutics $HZNP Research Coverage Started at Guggenheim https://t.co/8OJz0YJcPE #stocks
September 12th 2019, 8:09am
AmericanBanking @AmericanBanking
Horizon Therapeutics PLC $HZNP Given Consensus Rating of “Buy” by Brokerages https://t.co/RvCqYj3VKl #stocks
September 12th 2019, 7:09am
semodough @semodough
@syinvesting $HZNP upside potential to revenue &margins on continued commercial execution &positive mix shift, and… https://t.co/W1K8grK6a7
September 12th 2019, 6:09am
Tickeron @Tickeron
$HZNP in Uptrend: 50-day Moving Average broke above 200-day Moving Average on November 24, 2017. View odds for this… https://t.co/gBwOO3IeKN
September 11th 2019, 12:09pm
Tickeron @Tickeron
$HZNP in Uptrend: 50-day Moving Average moved above 200-day Moving Average on November 24, 2017. View odds for this… https://t.co/yD0znyWb5z
September 10th 2019, 12:09pm
fda_tracker @fda_tracker
$HZNP New PDUFA Date 2020-03-08 HORIZON THERAPEUTICS PLC Link:https://t.co/gJT07tvIMM Calendar:https://t.co/sCt1qKoMdr
September 10th 2019, 9:09am
CowenResearch @CowenResearch
Ken Cacciatore’s published report this morning details results of clinician checks on $HZNP Tepro for thyroid eye d… https://t.co/Y5KzQ4HuNS
September 10th 2019, 7:09am
WeekHerald @WeekHerald
Horizon Therapeutics $HZNP Downgraded to “Hold” at BidaskClub https://t.co/6UnPsdoDK8
September 10th 2019, 5:09am
ThisLincolnian @ThisLincolnian
BidaskClub Lowers Horizon Therapeutics $HZNP to Hold https://t.co/f1uwbmTB2T
September 10th 2019, 5:09am
FlyOnTheWallHQ @FlyOnTheWallHQ
Horizon Pharma $HZNP Will Confirm Acquisition Talks With Amgen $AMGN In New York City https://t.co/1DDq2ca9q8… https://t.co/lNlTKFr2Jn
September 9th 2019, 10:09pm
Gambiste1 @Gambiste1
RT @MarketCurrents: $HZNP - FDA accepts Horizon's teprotumumab application for thyroid eye disease https://t.co/pOeNI0slOi
September 9th 2019, 2:09pm
SeekingAlpha @SeekingAlpha
$HZNP - Horizon Therapeutics: A Recession Resistant Pick With Upside Potential https://t.co/huKhnLeqfm
September 9th 2019, 2:09pm
MarketCurrents @MarketCurrents
$HZNP - FDA accepts Horizon's teprotumumab application for thyroid eye disease https://t.co/pOeNI0slOi
September 9th 2019, 1:09pm
mlbtvtalk @mlbtvtalk
@syinvesting @US_FDA $HZNP So this stock is dead money for another 6 months.
September 9th 2019, 12:09pm
Tickeron @Tickeron
$HZNP in Uptrend: 50-day Moving Average broke above 200-day Moving Average on November 24, 2017. View odds for this… https://t.co/a3F6kT9jq3
September 9th 2019, 12:09pm
syinvesting @syinvesting
$HZNP announced the @US_FDA has granted Priority Review of the teprotumumab BLA for the treatment of TED. PDUFA dat… https://t.co/Ysofqmv4qg
September 9th 2019, 11:09am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.